Press Releases Ypsomed Group

Burgdorf – Parents and caregivers of children with diabetes can now follow their child's glucose and insulin data via the mylife CamAPS FX app on their own personal smartphone. The new "Companion remote monitoring" feature is fully integrated into the app. It gives parents and caregivers better control and peace of mind.

Even when the child is at school the parents can follow its diabetes therapy data via the Companion remote monitoring
Even when the child is at school the parents can follow its diabetes therapy data via the Companion remote monitoring

Parents get an informative overview through Companion remote monitoring within the mylife CamAPS FX app, as they can view all their child's therapy data at any time via their smartphone – regardless of whether the child is at school, enjoying his or her hobbies or meeting friends. Especially at night, remote diabetes monitoring allows a relaxed sleep and can relieve caregivers considerably. Besides the common display of Continuous Glucose Monitoring (CGM) data, also insulin delivery data, Boost & Ease-Off usage, pump information and other relevant mylife CamAPS FX information can simply be shared with parents and caregivers.

Freedom of choice with mylife Loop – rollout in further countries

mylife YpsoPump and mylife CamAPS FX is the only automated insulin delivery (AID) system that can be connected either to the Dexcom G6 sensor from Dexcom or to the FreeStyle Libre 3 sensor from Abbott. It is designed to help people with Type 1 diabetes to better control their glucose levels and reduce the burden of daily diabetes management.

Abbott's FreeStyle Libre 3 sensor has been compatible with mylife Loop in Germany since December 2022. This compatibility will be rolled out in Switzerland, UK and the Netherlands in the first half of 2023.

The mylife Loop offer is currently available for Android, iOS will follow.

High resolution image

Susanne Köhler
Head of Public Relations
Ypsomed Holding AG

Retour